NFKB1 and Alzheimer disease: Recently, Han et al. reported that TMEM232 is overexpressed in the skin tissues of AD patients and mice, promoting inflammatory responses via the NF-κB and STAT3 pathways, which exacerbates the inflammatory environment and results in the formation of AD-like lesions [46].